Navigation Links
Tylenol Recall Expands to Include Other OTC Meds

FDA criticizes manufacturer for slow reaction to consumer complaints ,,

FRIDAY, Jan. 15 (HealthDay News) -- As a Johnson & Johnson subsidiary expanded its recall of some of its over-the-counter drugs on Friday, federal health officials said a warning letter has been sent to the company for failing to act quickly to take the products off the shelves after customers were sickened by a moldy smell on the medications.

"This morning, McNeil Consumer Healthcare voluntarily expanded its recall of over-the-counter drugs to include approximately 500 lots of products," Deborah M. Autor, director of the Office of Compliance in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration, said during a morning teleconference Friday.

The company's recall started last September and was limited to certain lots of Tylenol, although that recall was expanded in December. The recall now includes certain lots of Motrin, Benadryl, Rolaids and St. Joseph aspirin.

To date, there have been some 70 reports from consumers about the problem, and in some cases using these products has resulted in nausea, stomach pain, vomiting and diarrhea, Autor said.

The company believes the contamination was caused by a chemical used to treat the wooden pallets on which packaging material is transported and stored. The chemical, 2,4,6-tribromoanisole (TBA) also occurs naturally and has been blamed for giving wine a moldy taste.

"The health effects of this chemical have not been well-studied, but no serious events have been documented in the medical literature," Autor said.

According to McNeil, it is possible that the TBA leeched into the packaging material and then into the products themselves.

While Autor commended the company for broadening its recall to include products that consumers have not complained about, she chastised them for acting too slowly to report and investigate the problem.

The first complaints of a musty odor in Tylenol Arthritis Relief Easy Cap products reached company officials in May 2008, but it wasn't until September of that year that the company began to investigate the problem.

Then, McNeil did not notify the FDA of the problem until September 2009, Autor said. "When something smells bad -- literally or figuratively -- companies must aggressively investigate and take all necessary action to solve the problem," she stressed.

Since then, the agency has repeatedly urged McNeil to identify the source of the problem and to recall affected products. Under current law, the FDA cannot order a recall, Autor noted.

The first recall of products was in early September 2009; the recall was expanded in December 2009 to include all Tylenol Arthritis Relief caplets. In addition, the FDA inspected McNeil's primary manufacturing plant in Las Piedras, Puerto Rico.

Based on this data, the agency has sent McNeil a warning letter citing multiple violations of "good manufacturing practice requirements," Autor said. "[The] FDA also warned McNeil for failing to report quality problems to the agency."

"McNeil and all drug manufacturers have a corporate responsibility to ensure their products are high-quality, safe and effective," Autor said. "When a problem arises with their products they must be proactive, quick and thorough in order to assure the quality, safety and effectiveness of their products and protect consumers."

For its part, McNeil said this in a statement released Friday: "In addition to the product recall, McNeil Consumer Healthcare is continuing their investigation into this issue and is taking further actions that include ceasing shipment of products produced using materials shipped on these wood pallets and requiring suppliers who ship materials to our plants to discontinue the use of these pallets. We will continue to closely monitor and evaluate the situation and consult with the FDA."

Recalled products include specific lots of:

  • Regular Strength Tylenol
  • Extra Strength Tylenol
  • Children's Tylenol
  • Tylenol 8-Hour
  • Tylenol Arthritis
  • Tylenol PM
  • Tylenol Simply Sleep
  • Children's Motrin
  • Motrin IB
  • Benadryl
  • Rolaids
  • St. Joseph aspirin

More information

For more information on the recall, visit the McNeil Consumer Healthcare.

SOURCE: Jan. 15, 2010, teleconference with Deborah M. Autor, director, Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. The Makers of TYLENOL(R) Warming Liquids Offer Free Warming Taxi Rides in Select Philadelphia Areas
2. The Makers of TYLENOL(R) Warming Liquids Offer Free Warming Taxi Rides in Washington, D.C.
3. Its Cold Outside! Warm Up in Select Downtown Chicago Heated Bus Shelters Courtesy of TYLENOL(r) Warming Liquids
4. Its Cold Outside! Warm Up in Select Downtown Boston Heated Bus Shelters Courtesy of TYLENOL(r) Warming Liquids
5. Terri Lynne Lokoff Child Care Foundation Announces Recipients of the 2009 Terri Lynne Lokoff/Childrens TYLENOL(R) National Child Care Teacher Awards(TM)
6. Tylenol May Weaken Effectiveness of Kids Vaccines
7. Tylenol May Ease Headaches and Heartaches
8. TYLENOL Recall Confirms Congress, FDA Must Regulate Wood Pallets to Prevent Threats to U.S. Food, Drug Supply
9. Fairbank Farms Voluntarily Recalls 85% Ground Round Beef Patties Sold Fresh from Shaws Due to Possible Health Risk
10. Friends of Mel Announce Recall of Jewelry Due to Lead
11. After Infant Gripe Water Recall Scare, Homeopathic Medicine Offers Safe Alternative
Post Your Comments:
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... for physicians and athletic programs, launches new Wimbledon Athletics Facebook page ... testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under the age ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... board certified facial plastic surgeon specializing in both surgical and non-surgical treatments, announced ... Skin Spa at Hobgood Facial Plastic Surgery. , Highly trained and nationally ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... “While riding ... an inventor, from Bronx, N.Y. “I thought there had to be a convenient and ... the PROTECTOR. , The PROTECTOR enables disabled individuals to safely travel during cold or ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... cancer, I found that regular bras were incredibly uncomfortable," said an inventor from ... specialized bra." , She developed the patent-pending RECOVERY BRA for added comfort and ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bcureful—a non-profit organization devoted to ... raising public awareness of the disorder while helping to bring expert medical care ... to bolster progress at the Tuberous Sclerosis Complex Center at Ann & Robert ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... plc (NYSE: AGN ) today announced that it has ... Attorney General,s Office to end the litigation under ... the Attorney General over the decision of Forest Laboratories, Inc., ... now generic version of memantine immediate release tablets.  Under the ... counterclaims against New York , and has ...
(Date:11/25/2015)... 2015 Allergan plc (NYSE: AGN ... Therapeutics, a start-up  biotechnology company focused on the ... and funded by the F-Prime Biomedical Research Initiative ... an exclusive collaboration to support the discovery and ... (ASD) and Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... November 25, 2015 --> ... blood glucose devices was valued at $11,171.1 million in ... CAGR of 5.7% during 2015 - 2022. The global ... increasing prevalence of diabetes. In addition, the increase in ... also contributing to the growth of the market. Furthermore, ...
Breaking Medicine Technology: